The Global Organ Preservation Market is expected to grow at a high CAGR during the forecasting period (2020-2027).
The process of organ transplantation involves an organ removal from a donor body, transporting the organ, and transplanting into another body, all while preserving the organ without significant damage.
Creating hypothermia by reducing the organ temperature may help preservation, but different body organs need precise and appropriate storage environments to maintain their anatomical and physiological processes.
The global market for the organ preservation market is primarily driven by the rising cases of multiple organ failure. The increasing number of solid-organ transplantation procedures coupled with an aging population are expected to promote market growth.
Other factors such as the growing government and NGO initiatives to encourage organ donation along with the increasing awareness of organ donations assist the market development. Technological advancements, for example, the normothermic machine perfusion which is a new paradigm for organ preservation also contribute to market growth.
However, the high cost of organ transplantation, a significant gap between the number of organs donated and organs required annually and limited medical reimbursements for organ donation and transplantation may hinder the market progress.
By technique, the global organ preservation segment is divided into static cold storage, hypothermic perfusion preservation, normothermic machine perfusion, and others. The preservation technique sector is led by static cold storage share.
It is owing to the rise in its demand due to its cost-effective techniques and user-friendly for doctors. On the other hand, hypothermic perfusion preservation is anticipated to experience the fastest growth during the forecast period as a result of the benefits of organ preservation it provides for a more extended period.
By solutions, the global organ preservation market is segmented into University of Wisconsin solution, custodial HTK, pervades, Collins solution, citrate solutions, and others. Among these, Custodiol HTK Solution is anticipated to be the fastest growing in the forecast period.
It is attributed to the rise in the preservation of various organs such as kidneys, pancreas, liver, and lungs. The University of Wisconsin solution segment is anticipated to account for the most substantial portion of the market owing it to its extensive usage in the storage of kidney, liver, and pancreas, less histological damage, improved physiological function of organs, and better outcomes after transplantation.
Based on organ type, the global organ preservation market is divided into the lung, kidneys, heart, liver, and other organs. Kidney preservation holds the most significant share in the organ preservation market due to the rising elderly population coupled with the rise in the occurrence of kidney failures.
According to National kidney foundation, over 80% of all people who get therapy for kidney failure are in prosperous nations with global access to large elderly populations and health care. According to the National Kidney Foundation, in 2016, around 121,678 people are waiting for lifesaving organ transplants in the U.S., among which, approximately 100,791 people are waiting for kidney transplants.
North America dominates the global Organ Preservation Market, and it is primarily attributed to the rising geriatric population leading to the higher occurrence of organ failures.
The growing prevalence of cardiovascular diseases and the increasing cases of kidney failure are likely to enhance the growth of organ preservation. Furthermore, factors such as high spending of GDP in healthcare, growing government initiatives, and reimbursement policies in advanced medical treatment options are likely to enhance the growth of organ preservation market in the region.
Moreover, the extensive research activities are undertaken by a majority of prominent players in the area, and rising demand for technologically advanced treatment will propel the market.
For instance, according to a report by the National Chronic Kidney Disease in 2017, chronic kidney diseases are common amongst adults in the U.S., and about 30 million people of the U.S. are expected to have chronic kidney disease.
But extensive R&D on the growing organs by stem cell therapy and the enormous gap between demand and supply of organs can hinder the market growth of organ preservation.
According to the U.S. Government Information on Organ Donation and Transplantation, 2017, over 114,000 people in the U.S. were on the national transplant waiting list, but only 34,770 transplants were performed that year.
Asia-Pacific region is expected to be the fastest growing market during the forecast period, owing to the increasing prevalence of chronic diseases.
China is expected to show the fastest growing due to its large population, raising awareness about organ donation, favorable government policies, new regulatory framework, and accessibility of new treatment methods. Moreover, rising healthcare expenditure boosts voluntary organ donation in the Asia Pacific region.
However, lack of awareness and religious beliefs, particularly in India and Japan may hamper the growth of the organ preservation market.
Key players are adopting strategies such as mergers and acquisitions, partnerships, and regional expansion to stand out as strong competitors in the market. New product launches along with increased focus on R&D are other ways the leading players improve their market presence.
January 2019, TransMedics, Inc. developed the Organ Care System (OCS), an innovative, portable system that delivers warm, nutrient-rich blood to the organ, allowing it to function outside of the body and enabling organ optimization and assessment. The system integrates a compact wireless monitor, an organ-specific perfusion module, and proprietary solutions for organ maintenance.
July 2018, Aferetica srl, an innovative start-up specializing in purification therapies, and CytoSorbents Corporation, a critical care immunotherapy leader using sorbent-based blood purification to treat life-threatening conditions, announced the debut and scientific presentation of Africa’s ProLife ex-vivo organ perfusion system with CytoSorbents’ PerSorb adsorber.
In 2015, Dr. Franz Köhler Chemie, the market-leading organ protective solution of the company, opened a new manufacturing site for Custodial solutions.
Visualize the composition of the global Organ Preservation Market across each indication, in terms of type and treatment options, highlighting the critical commercial assets and players.
Identify business opportunities in global Organ Preservation Market by analyzing trends and co-development deals.
Excel data sheet with thousands of data points of the global Organ Preservation Market – level 4/5 segmentation.
PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
Product mapping in excel for the principal products of all major market players.
Equipment Suppliers/ Buyers
Service Providers/ Buyers
Industry Investors/Investment Bankers
Education & Research Institutes
1.1. Research Methodology
1.2. Scope of the market
2.1. Key Trends and Developments
3.3. Supply Chain Analysis
3.5. Key Developments
4.1. By Technique
4.1.1. Static Cold Storage (SCS)
4.1.2. Hypothermic Perfusion Preservation (HPP)
4.1.3. Normothermic Machine Perfusion
4.2. By Preservation Solution
4.2.1. University of Wisconsin Solution (UW Solution)
4.2.2. Custodiol HTK
4.2.4. Collins Solution
4.2.5. Citrate Solutions
4.3. By Organ Type
4.3.5. Other Organs (Pancreas, Intestine)
5.1. Geographic Overview
5.2. North America
5.3.4. Rest of Europe
5.4. South America
5.4.3. Rest of South America
5.5. Asia Pacific
5.5.5. Rest of Asia Pacific
5.6. Rest of World
6.1. Competitive Scenario
6.2. Key Strategies adopted by Manufacturers
6.3. Product Benchmarking
7.1. XVIVO Perfusion AB
7.2. CryoLife, Inc.
7.3. Lifeline Scientific
7.4. BioTime, Inc.
7.5. Claris Lifesciences Limited
7.6. BioLife Solutions, Inc.
7.7. Dr. Franz Kohler Chemie GmbH
7.8. Bristol-Myers Squibb
7.9. Tolerotech, Inc.
7.10. 21st Century Medicine
8.2. List of Tables
8.3. Expert Panel Validation
8.5. Contact Us
Get your FREE SAMPLE PROPOSAL with a single click!